Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/32449
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorJiménez del Río, Marlene-
dc.contributor.authorVélez Pardo, Carlos Alberto-
dc.date.accessioned2022-11-29T21:30:04Z-
dc.date.available2022-11-29T21:30:04Z-
dc.date.issued2006-
dc.identifier.issn0897-7194-
dc.identifier.urihttps://hdl.handle.net/10495/32449-
dc.description.abstractABSTRACT The role of insulin-like growth factor (IGF-1) as neural survival factor for the treatment of Alzheimer’s disease has recently gained attention. The present study shows that IGF-1 protects lymphocytes from (10, 30 mM) Ab[25–35] and (25, 50, 100mM) H2O2-induced apoptosis through NF-kB activation and p53 down regulation involving the phosphoinositide 3-kinase (PI-3K)–dependent pathway as demonstrated by using either (25 mM) LY294002 (PI-3K inhibitor), (10 nM) ammonium pyrrolidinedithiocarbamate (PDTC; NF-kB inhibitor), 50 nM pifithrin-a (PFT; p53 inhibitor) or by using immunocytochemistry detection of NF-kB and p53 transcription factors activation. Importantly, IGF-1, PDTC and PFT were able to protect and rescue lymphocytes pre-exposed to 10 mM Ab[25–35], even when the three compounds were added up-to 12 h post- Ab[25–35] exposure. Altogether these results suggest that survival/rescue of lymphocytes from Ab[25–35] toxicity is determined by p53 inactivation via IGF-1/ PI-3K pathway.spa
dc.format.extent12spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherHarwood Academic Publishers; Taylor and Francisspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/co/*
dc.titleInsulin-like growth factor-1 prevents Aβ[25-35] / (H2O2)-induced apoptosis in lymphocytes by reciprocal NF-κB activation and p53 inhibition via PI3K-dependent pathwayspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Neurociencias de Antioquiaspa
dc.identifier.doi10.1080/08977190500361788-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1029-2292-
oaire.citationtitleGrowth Factorsspa
oaire.citationstartpage67spa
oaire.citationendpage78spa
oaire.citationvolume24spa
oaire.citationissue1spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.publisher.placeYverdon-Les-Baibs, Suizaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsInsulin-Like Growth Factor I-
dc.subject.decsFactor I del Crecimiento Similar a la Insulina-
dc.subject.decsPhosphatidylinositol 3-Kinases-
dc.subject.decsFosfatidilinositol 3-Quinasas-
dc.subject.decsApoptosis-
dc.subject.decsAmyloid beta-Peptides-
dc.subject.decsPéptidos beta-Amiloides-
dc.subject.decsHydrogen Peroxide-
dc.subject.decsPeróxido de Hidrógeno-
dc.subject.decsTumor Suppressor Protein p53-
dc.subject.decsProteína p53 Supresora de Tumor-
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1080/08977190500361788?scroll=top&needAccess=truespa
dc.description.researchgroupidCOL0010744spa
dc.relation.ispartofjournalabbrevGrowth Factors.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
JimenezMarlene_2006_GrowthFactorPrevents.pdfArtículo de investigación852.92 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons